PEPTIDE-BASED GASTROINTESTINAL DISORDERS THERAPEUTICS MARKET ANALYSIS

Peptide-Based Gastrointestinal Disorders Therapeutics Market, by Drugs (Plecanatide (Trulance), Teduglutide, and Linaclotide), by Application (Short Bowel Syndrome, Chronic Constipation, Irritable Bowel Syndrome, and Others), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI2028
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Peptide-Based Gastrointestinal Disorders Therapeutics Market Key Players

Key players operating in the global peptide-based gastrointestinal disorders therapeutics market include Ironwood Pharmaceuticals, Inc., NPS Pharmaceuticals, Inc., Synergy Pharmaceuticals Inc., Astellas Pharma Inc., Allergan plc., and Cipher Pharmaceuticals Inc.